Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

The recent imposition of a 27 per cent reciprocal tariff on Indian exports by the United States, while exempting the ...

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

Indian pharmaceutical exports to the U.S. were valued at approximately USD 8 billion, with the industry witnessing an 8 percent compound annual growth rate (CAGR) over FY15-24.

Analysts said tariffs would send prescription drug prices higher. Generic drugs and ingredients that are largely made ...

The talks between the administration and the industry, which have been taking place behind closed doors, have given some ...

LONDON/NEW YORK, April 1 (Reuters) - Drugmakers are lobbying U.S. President Donald Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the charges and ...

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

The exemption applies broadly to all pharmaceutical products, ensuring that the drugmakers avoid immediate cost pressures ...